Acetic Acid

Acetic Acid

SCHEMBL2950220

CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].O.[Tm+3]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.80
CA4 P22748 3/20 0.54
LMNA P02545 2/20 0.46
TSHR P16473 2/20 0.42
FFAR3 O14843 2/20 0.42
THPO P40225 1/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
ALOX15 P16050 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
FAHD1 Q6P587 1/20 0.39
CES1 P23141 1/20 0.35
ALDH1A1 P00352 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL28487885 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL28146664 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL8582052 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL8068073 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL7909497 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL8897305 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL1971540 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL57597 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL21271597 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3
Acetic Acid SCHEMBL26684797 1.00 CA1 (0.80) CA1CA4LMNATSHRFFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117926221-A Device for forming corrosion-resistant coating and method for forming corrosion-resistant coating 中微半导体设备(上海)股份有限公司 2024-04-26 CN claimed
CN-114350359-B Three-mode luminous carbon dot-based room-temperature phosphorescent composite material and preparation method, application and use method thereof 华南农业大学 2023-04-07 CN claimed
CN-114350359-A Three-mode luminous carbon dot-based room-temperature phosphorescent composite material and preparation method, application and use method thereof 华南农业大学 2022-04-15 CN claimed
EP-2655482-A1 POLYHETEROSILOXANE COMPOSITION INCLUDING LANTHANIDE METAL Dow Corning Corporation (US) 2013-10-30 EP claimed
WO-2012088439-A1 POLYHETEROSILOXANE COMPOSITION INCLUDING LANTHANIDE METAL DOW CORNING CORPORATION (US) 2012-06-28 WO claimed
CN-119462111-B Multi-element rare earth silicate/silicon oxygen carbon nano multiphase ceramic and preparation method thereof 中南大学 2026-05-12 CN disclosed
WO-2025121735-A1 PHARMACEUTICAL COMPOSITION COMPRISING UPCONVERSION NANOPARTICLES FOR PREVENTING OR TREATING CANCER 부산대학교 산학협력단 2025-06-12 WO disclosed
US-20250122424-A1 LOW PHONON ENERGY NANOPARTICLES BASED ON ALKALI LEAD HALIDES AND METHODS OF SYNTHESIS AND USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-04-17 US disclosed
CN-119612466-A Lanthanide phosphate sub-nanowire ball and preparation method and application thereof 浙江工业大学绍兴研究院 2025-03-14 CN disclosed
CN-119462111-A Multi-element rare earth silicate/silicon oxygen carbon nano multiphase ceramic and preparation method thereof 中南大学 2025-02-18 CN disclosed
WO-2024237543-A1 MULTI-FUNCTIONAL PARTICLES FOR NEAR-INFRARED IMAGING GUIDANCE AND PHOTOTHERMAL THERAPY AND COMPOSITE COMPRISING SAME 한양대학교 산학협력단 2024-11-21 WO disclosed
US-12037529-B2 Luminescent layered composition and a method for using the composition RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2024-07-16 US disclosed
US-7531681-B2 Process for the ammoxidation of propane and isobutane INEOS USA LLC (US) 2009-05-12 US disclosed
WO-2009048553-A2 PROCESS FOR THE AMMOXIDATION OR OXIDATION OF PROPANE AND ISOBUTANE INEOS USA LLC (US) 2009-04-16 WO disclosed
WO-2009005670-A2 MIXED METAL OXIDE CATALYSTS FOR THE AMMOXIDATION OF PROPANE AND ISOBUTANE INEOS USA LLC (US) 2009-01-08 WO disclosed
US-20090005586-A1 MIXED METAL OXIDE CATALYSTS FOR THE AMMOXIDATION OF PROPANE AND ISOBUTANE INEOS USA LLC 2009-01-01 US disclosed
US-20080200716-A1 Mixed metal oxide catalysts for the ammoxidation of propane and isobutane INEOS USA LLC 2008-08-21 US disclosed
US-20080200715-A1 PROCESS FOR THE AMMOXIDATION OF PROPANE AND ISOBUTANE INEOS USA LLC 2008-08-21 US disclosed
US-20080103325-A1 Mixed metal oxide catalysts for the ammoxidation of propane and isobutane INEOS USA LLC 2008-05-01 US disclosed
US-20080103326-A1 Consistent performance; high yield gas phase conversion to acrylonitrile and methacrylonitrile; includes molybdenum, vanadium, antimony, niobium, lanthanides with titanium, tin, germanium, zirconium and/or hafnium INEOS USA LLC 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12037529-B2 Luminescent layered composition and a method for using the composition CAPG, CD47, CD63 CA1 415/4885CA4 520/4885LMNA 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.